Page-2 of COVAXIN Vaccine Current Affairs, GK & News
Govt to support Public Sector Companies for Vaccine Production
Union Government has decided to support some public sector companies with grants under the Mission COVID Suraksha to boost covid-19 vaccine production. Key Points Among the companies, one is Hyderabad based Indian Immunological limited (IIL), a facility under PSU named “National Dairy Development Board”. IIL and Bharat Biotech have signed a technical agreement for IIL ..
Month: Current Affairs - May, 2021
Category: Government Schemes Current Affairs
Topics: Biotechnology Industry Research Assistance Council (BIRAC) • COVAXIN Vaccine • COVID Suraksha Mission • COVID-19 • Department of Biotechnology (DBT)
PM Takes First Dose of COVID-19 Vaccine
The Prime Minister of India, Narendra Modi, takes first dose of COVID-19 vaccine on March 1, 2021 at AIIMS, New Delhi. After vaccination, he appealed to those people who are eligible to get their vaccination done. Covid-19 Vaccination in India The national vaccination programme to for the virus called “SARS-CoV-2” which has caused ongoing Covid-19 ..
Month: Current Affairs - March, 2021
Category: India Nation & States Current Affairs
Topics: COVAXIN Vaccine • COVID-19 • Global Covid-19 Vaccination Plan • Narendra Modi • Serum Institute of India
SII’s Covishield gets emergency-use nod from DGCI
The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by the University of Oxford and the British Pharmaceutical major Astra Zeneca. In India, the vaccine ..
Month: Current Affairs - January, 2021
Category: India Nation & States Current Affairs
Topics: AstraZeneca • Bharat Biotech Limited • Clinical trials • COVAXIN • COVAXIN Vaccine • COVID-19 vaccine • Covishield • Director controller General of India • Serum Institute of India
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The trials are the largest clinical trials that is conducted for COVID-19 vaccine in the country. ..
Month: Current Affairs - November, 2020
Category: India Nation & States Current Affairs
Topics: Bharat Biotech • COVAXIN • COVAXIN Vaccine • ICMR • Moderna • National Institute of Virology • Pfizer • SPUTNIK V
Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials
The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech. At NIV Pune, the ..
Month: Current Affairs - June, 2020
Category: Science & Technology Current Affairs
Topics: Bharat Biotech Limited • Chikungunya • COVAXIN Vaccine • COVID-19 • Drug Controller General of India • Hyderabad • National Institute of Virology • Polio • Rabies • Rotavirus